Moreover, activation or expansion of CD141+ mDCs using TLR agonists or similar compounds prior immune check‐point blockade might improve the effectiveness of this type of immunotherapies, which might be relevant, not only as a potential antiviral strategy, but also as cancer immunotherapy, including adoptive transfer strategies using this cell type. The gene discussed is THBD; the disease is cancer.